Zantac Lawsuits

A Zantac lawsuit is a claim arising from a person who took Zantac and ranitidine contaminated with N-nitrosodimethylamine (NDMA) and later developed cancer. The Zantac lawsuit is an active lawsuit. Those filing Zantac lawsuits are seeking compensation from drug manufacturers for the stomach, bladder, and other cancers associated with NDMA, a probable human carcinogen. If […]

A Brief History Of The Zantac Recall

In September 2019, a Connecticut pharmacy notified the U.S. Food and Drug Administration (FDA) that it had found the cancer-causing chemical N-Nitrosodimethylamine (NDMA) in their Zantac inventories and its generic form, ranitidine. Sanofi, Zantac’s brand-name manufacturer, and 14 generic manufacturers recalled the medication in the United States. Pharmacies like CVS, Rite Aid, Walgreens, and Walmart […]

New Findings See Cancer-Causing Carcinogens Increasing in our Medication

Scary thought. We rely on our doctors to recommend the right medication for our ailments. We rely on the FDA to ensure the safety of our medication. However, new evidence suggests that drugs can change and produce N-nitrosodimethylamine, NDMA, a probable carcinogen despite safety measures. Drugs previously thought safe are now being linked to cancer. […]

Why is the Dept. of Justice Investigating Zantac Maker?

Zantac and generic forms of this medication, both prescription and over the counter, have faced significant recalls over the last year. Now, The US Department of Justice (DOJ) is investigating two Zantac manufacturers. The DOJ is attempting to determine whether or not the drug manufacturers violated federal laws while selling the medication. Here, we want […]

Zantac Linked To Cause Cancer

Heartburn is a tragedy. It creeps up on you and then hits like a freight train. Typically people know what triggers their heartburn, but you have to learn the hard way—by eating something you love and then feeling the after-effects. When you google heartburn relief, you will find drugs like Nexium, Pepcid, or Prilosec. What […]

Drug Companies Investigated For Failing To Disclose Zantac Risks

At Colson Hicks Eidson, we have regularly discussed the cancer risks posed by Zantac and other generic forms of ranitidine. Over the last year, these medications have been recalled, and major companies have pulled them from their shelves. Now, federal investigators are looking into whether two drugmakers may have known about a probable carcinogen in […]

FDA Lists Alternatives To Zantac As They Pull The Drug From Shelves

Zantac and other ranitidine products have been under close scrutiny since last year after testing found high levels of a carcinogen known as N-nitrosodimethylamine (NDMA)inside the medications. Many pharmacies and other retailers stopped selling prescription Zantac and over-the-counter ranitidine products. Recently, the US Food and Drug Administration (FDA) asked manufacturers of Zantac and generic equivalents […]

Have You Taken Zantac? Here Are Some Symptoms You Need To Be Aware Of

Recently, the United States Food and Drug Administration (FDA) asked manufacturers to pull Zantac and any generic versions of ranitidine off the shelves. Over the last year, it has become abundantly clear that this medication could contain unsafe levels of a carcinogenic chemical called N-nitrosodimethylamine (NDMA). There have been several lawsuits filed against the manufacturers […]

The Military Has Asked Service Members To Stop Taking Zantac

The popular heartburn medication Zantac has been in the news plenty over the last few weeks. Recently, the US Food and Drug Administration (FDA) ordered that all prescription Zantac and over-the-counter ranitidine products be withdrawn from the market due to the drug potentially containing a cancer-causing carcinogen. At Colson Hicks Eidson, our award-winning product liability […]

FDA Finally Asks For Complete Recall Of Zantac

Over the last year, testing by private laboratories indicated that prescription and over-the-counter Zantac could contain high levels of a carcinogenic chemical. Upon this discovery, many major pharmacies pulled Zantac and other ranitidine products from their shelves. Now, The US Food and Drug Administration (FDA) has formally asked the manufacturers to pull these drugs from […]